IFNA1 and COVID-19: In addition to perturbed lower respiratory tract and lung immune landscapes for COVID-19 patients, persistently increased levels of IFN-α/β and IFN-λ in the lungs of patients with severe COVID-19 can be another key issue, given their potential to interfere with lung epithelial cell repair and recovery, especially IFN-λ [88–90].